MetaVia Inc. SEC filings MTVA
MetaVia Inc. has 633 filings in SEC EDGAR's recent list, going back to Apr 8, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| S-8 | Employee stock plan registration | Jun 8, 2026 | — |
| 424B3 | Prospectus | Apr 7, 2026 | — |
| S-8 | Employee stock plan registration | Apr 3, 2026 | — |
| POS AM | Filing | Apr 3, 2026 | — |
| 424B4 | Prospectus | Jan 16, 2026 | — |
| S-1MEF | Form s-1mef | Jan 15, 2026 | — |
| S-1/A | Amended registration statement | Jan 12, 2026 | — |
| FWP | Free writing prospectus | Jan 6, 2026 | — |
| S-1 | Registration statement | Jan 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| S-3 | Shelf registration | Jul 2, 2025 | — |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| POS AM | Filing | Mar 27, 2025 | — |
| 424B3 | Prospectus | Jul 24, 2024 | — |
| S-1 | Registration statement | Jul 18, 2024 | — |
| 424B5 | Prospectus supplement | Jun 25, 2024 | — |
| S-3 | Shelf registration | Apr 12, 2024 | — |
| S-8 | Employee stock plan registration | Apr 17, 2023 | — |
| 424B3 | Prospectus | Feb 1, 2023 | — |
| S-3 | Shelf registration | Jan 23, 2023 | — |
| 424B4 | Prospectus | Nov 7, 2022 | — |
| S-1/A | Amended registration statement | Nov 3, 2022 | — |
| FWP | Free writing prospectus | Oct 24, 2022 | — |
| S-1/A | Amended registration statement | Oct 24, 2022 | — |
| S-1 | Registration statement | Sep 16, 2022 | — |
| S-8 | Employee stock plan registration | Nov 4, 2021 | — |
| 424B5 | Prospectus supplement | Oct 4, 2021 | — |
| S-3 | Shelf registration | May 14, 2021 | — |
| 424B3 | Prospectus | Apr 30, 2021 | — |
| S-3 | Shelf registration | Apr 21, 2021 | — |
| 424B3 | Prospectus | Feb 1, 2021 | — |
| 424B3 | Prospectus | Jan 29, 2021 | — |
| S-3 | Shelf registration | Jan 25, 2021 | — |
| 424B5 | Prospectus supplement | Apr 15, 2020 | — |
| S-8 | Employee stock plan registration | Apr 1, 2020 | — |
| 424B3 | Prospectus | Nov 6, 2019 | — |
| S-4/A | Filing | Nov 4, 2019 | — |
| S-4/A | Filing | Oct 30, 2019 | — |
| S-4/A | Filing | Oct 11, 2019 | — |
| S-4 | Registration for a merger or exchange | Sep 3, 2019 | — |
| S-8 | Employee stock plan registration | Jul 16, 2019 | — |
| S-8 | Employee stock plan registration | Jun 5, 2018 | — |
| 424B5 | Prospectus supplement | Feb 9, 2018 | — |
| 424B5 | Prospectus supplement | Feb 7, 2018 | — |
| S-8 | Employee stock plan registration | Jan 24, 2018 | — |
| POS AM | Filing | Sep 1, 2017 | — |
| S-3 | Shelf registration | Sep 1, 2017 | — |
| 424B3 | Prospectus | Aug 14, 2017 | — |
| 424B3 | Prospectus | Aug 7, 2017 | — |
| 424B3 | Prospectus | Jul 27, 2017 | — |
| 424B3 | Prospectus | May 30, 2017 | — |
| 424B3 | Prospectus | May 24, 2017 | — |
| 424B3 | Prospectus | May 10, 2017 | — |
| 424B3 | Prospectus | Apr 21, 2017 | — |
| S-1 | Registration statement | Apr 13, 2017 | — |
| S-8 | Employee stock plan registration | Oct 3, 2016 | — |
| S-8 | Employee stock plan registration | Aug 9, 2016 | — |
| 424B4 | Prospectus | Aug 8, 2016 | — |
| FWP | Free writing prospectus | Aug 5, 2016 | — |
| S-1/A | Amended registration statement | Aug 4, 2016 | — |
| S-1/A | Amended registration statement | Jun 13, 2016 | — |
| S-1 | Registration statement | Apr 18, 2016 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638287
- Former names
- NeuroBo Pharmaceuticals, Inc. (until Nov 18, 2024); Gemphire Therapeutics Inc. (until Dec 31, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.